BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28339382)

  • 1. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2.
    Deleruyelle LJ
    Int J Pharm Compd; 2016; 20(6):447-454. PubMed ID: 28339382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3.
    Deleruyelle LJ
    Int J Pharm Compd; 2017; 21(1):6-16. PubMed ID: 28346192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1.
    Deleruyelle LJ
    Int J Pharm Compd; 2016; 20(5):359-364. PubMed ID: 28339370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
    Ruiz AD; Daniels KR
    Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of compounded bioidentical hormone therapy in menopausal women: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.
    McBane SE; Borgelt LM; Barnes KN; Westberg SM; Lodise NM; Stassinos M
    Pharmacotherapy; 2014; 34(4):410-23. PubMed ID: 24390902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks and effectiveness of compounded bioidentical hormone therapy: a case series.
    Davis R; Batur P; Thacker HL
    J Womens Health (Larchmt); 2014 Aug; 23(8):642-8. PubMed ID: 25111856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of compounded bioidentical hormone replacement therapy.
    Vigesaa KA; Downhour NP; Chui MA; Cappellini L; Musil JD; McCallian DJ
    Int J Pharm Compd; 2004; 8(4):313-9. PubMed ID: 23924704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
    L'Hermite M
    Climacteric; 2017 Aug; 20(4):331-338. PubMed ID: 28301216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
    Romero M
    Adv Nurse Pract; 2002 Nov; 10(11):47-8, 51-2. PubMed ID: 12478948
    [No Abstract]   [Full Text] [Related]  

  • 12. Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls.
    Zeng Z; Jiang X; Li X; Wells A; Luo Y; Neapolitan R
    PLoS One; 2018; 13(5):e0197064. PubMed ID: 29768475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compounded Bioidentical Menopausal Hormone Therapy: ACOG Clinical Consensus No. 6.
    Obstet Gynecol; 2023 Nov; 142(5):1266-1273. PubMed ID: 37856860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women.
    Pinkerton JV; Santoro N
    Menopause; 2015 Sep; 22(9):926-36. PubMed ID: 25692877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioidentical Estrogen for Menopausal Depressive Symptoms: A Systematic Review and Meta-Analysis.
    Whedon JM; KizhakkeVeettil A; Rugo NA; Kieffer KA
    J Womens Health (Larchmt); 2017 Jan; 26(1):18-28. PubMed ID: 27603786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compounded or confused? Bioidentical hormones and menopausal health.
    Huntley AL
    Menopause Int; 2011 Mar; 17(1):16-8. PubMed ID: 21427420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioidentical hormone therapy in menopause: relevance in dermatology.
    Borda LJ; Wong LL; Tosti A
    Dermatol Online J; 2019 Jan; 25(1):. PubMed ID: 30710894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
    Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.